|
Market Closed -
Nasdaq
06:00:00 25/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 4.150 USD | -0.72% |
|
0.00% | -64.38% |
| 14/08 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 14/08 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 413M 363M 342M 312M 584M 39.62B 588M 4.11B 1.59B 20.16B 1.55B 1.52B 65.61B | P/E 2026 * |
-2.24x | P/E 2027 * | -4.91x |
|---|---|---|---|---|---|
| Enterprise Value | 413M 363M 342M 312M 584M 39.62B 588M 4.11B 1.59B 20.16B 1.55B 1.52B 65.61B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.17x |
| Free-Float |
83.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRY | Delayed | |
CBOE
| SPRY | Real-time |
Last Transcript: ARS Pharmaceuticals, Inc.
| 1 day | -0.72% | ||
| Current month | -30.83% | ||
| 1 month | -22.43% | ||
| 3 months | -60.63% | ||
| 6 months | -44.96% | ||
| Current year | -64.38% |
| 1 week | 4.07 |  | 4.57 |
| 1 month | 4.07 | | 6.12 |
| Current year | 4.07 | | 13.15 |
| 1 year | 4.07 | | 13.15 |
| 3 years | 3.35 | | 18.9 |
| 5 years | 2.55 | | 18.9 |
| 10 years | 2.55 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 05/08/2015 |
Donn Casale
CEO | Chief Executive Officer | 53 | 07/07/2026 |
Kathleen Scott
DFI | Director of Finance/CFO | 57 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Pratik Shah
CHM | Chairman | 56 | 08/11/2022 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 01/08/2021 |
Saqib Islam
BRD | Director/Board Member | 56 | 01/07/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Free | Executive/Senior Manager | 1,001,738 | 1.0073% | ||
| 1/7/26 | Free | Chief Executive Officer | 898,456 | 0.9048% | ||
| 24/6/26 | Free | Director | 30,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | 0.00% | -56.91% | +4.80% | 413M | |
| -0.21% | +4.66% | +10.23% | +32.15% | 48.01B | |
| +2.67% | +2.07% | +51.74% | +38.37% | 45.27B | |
| -1.38% | +1.84% | +9.13% | +88.88% | 40.93B | |
| +4.78% | +1.48% | +359.03% | +566.20% | 42.84B | |
| -0.62% | -1.61% | +5.30% | +46.02% | 29.6B | |
| +0.56% | +0.88% | +24.79% | +155.71% | 17.32B | |
| -0.23% | +1.49% | +27.14% | +41.72% | 15.34B | |
| +3.39% | -3.49% | - | - | 15.15B | |
| +7.38% | +2.34% | +3.80% | - | 14.84B | |
| Average | +1.57% | +0.92% | +48.25% | +121.73% | 26.97B | |
| Weighted average by Cap. | +1.53% | +1.55% | +77.08% | +149.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 130M 114M 108M 98.28M 184M 12.47B 185M 1.29B 501M 6.35B 488M 477M 20.65B | 191M 168M 158M 144M 270M 18.3B 272M 1.9B 735M 9.31B 716M 700M 30.3B |
| Net income | -184M -162M -153M -139M -260M -17.67B -262M -1.83B -710M -8.99B -691M -676M -29.26B | -85.02M -74.78M -70.5M -64.32M -120M -8.16B -121M -846M -328M -4.15B -319M -312M -13.52B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | USD 4.150 | -0.72% | 1,052,647 |
| 23/09/26 | USD 4.180 | -6.70% | 1,370,353 |
| 22/09/26 | USD 4.480 | +2.99% | 1,268,337 |
| 21/09/26 | USD 4.350 | +5.84% | 1,197,965 |
| 18/09/26 | USD 4.110 | -0.96% | 1,885,783 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRY Stock
Select your edition
All financial news and data tailored to specific country editions
